Merck KGaA Unit Files Patent Suit Against Sepracor
A subsidiary of the German pharmaceutical company Merck KGaA has filed a lawsuit alleging that an inhaled treatment for chronic obstructive pulmonary disease due to be released by Sepracor Inc. infringes...To view the full article, register now.
Already a subscriber? Click here to view full article